biota doesn't need those who missed the boat, page-6

I am under the impression that Biota feels no allegiance to DS in terms of manufacturing - the Japanese mentality to drug approvals, despite now only a facility in the US, is very, shall we say, Raw - this could be a big negative to Biota.

Whoever Biota choose to manufacture, there will be a commercial agreement/component - I now don't think partnering with the shrewd Japanese will give Biota any financial advantage - better to pick and choose from a bunch of contract manufacturing partners and the arrangement will be less clouded.